Search This Blog

Friday, October 4, 2019

Tandem Diabetes upped to Buy from Neutral by UBS

Target $75
https://www.benzinga.com/stock/TNDM/ratings

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.